PHENOLEPTIL 100 mg COMPRIMIDO PARA PERROS España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

phenoleptil 100 mg comprimido para perros

dechra regulatory b.v. - fenobarbital - comprimido - fenobarbital 100mg - fenobarbital - perros

PHENOLEPTIL 12,5 mg COMPRIMIDOS PARA PERROS España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

phenoleptil 12,5 mg comprimidos para perros

dechra regulatory b.v. - fenobarbital - comprimido - fenobarbital 12,5mg - fenobarbital - perros

PHENOLEPTIL 25 mg COMPRIMIDO PARA PERROS España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

phenoleptil 25 mg comprimido para perros

dechra regulatory b.v. - fenobarbital - comprimido - fenobarbital 25mg - fenobarbital - perros

PHENOLEPTIL 50 mg COMPRIMIDOS PARA PERROS España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

phenoleptil 50 mg comprimidos para perros

dechra regulatory b.v. - fenobarbital - comprimido - fenobarbital 50mg - fenobarbital - perros

Adcetris Unión Europea - español - EMA (European Medicines Agency)

adcetris

takeda pharma a/s - brentuximab vedotin - lymphoma, non-hodgkin; hodgkin disease - agentes antineoplásicos - hodgkin lymphomaadcetris is indicated for adult patients with previously untreated cd30+ stage iv hodgkin lymphoma (hl) in combination with doxorubicin, vinblastine and dacarbazine (avd). adcetris is indicated for the treatment of adult patients with cd30+ hl at increased risk of relapse or progression following autologous stem cell transplant (asct). adcetris is indicated for the treatment of adult patients with relapsed or refractory cd30+ hodgkin lymphoma (hl):following asct, orfollowing at least two prior therapies when asct or multi-agent chemotherapy is not a treatment option. systemic anaplastic large cell lymphomaadcetris in combination with cyclophosphamide, doxorubicin and prednisone (chp) is indicated for adult patients with previously untreated systemic anaplastic large cell lymphoma (salcl). adcetris is indicated for the treatment of adult patients with relapsed or refractory salcl. cutaneous t cell lymphomaadcetris is indicated for the treatment of adult patients with cd30+ cutaneous t cell lymphoma (ctcl) after at least 1 prior systemic therapy.